摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(6-(3-chloro(2-thienyl))-5-{2-[(4-fluorophenyl)carbonylamino]ethyl}-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-7-yl))-2,2,2-trifluoroacetamide | 846570-74-9

中文名称
——
中文别名
——
英文名称
N-(6-(3-chloro(2-thienyl))-5-{2-[(4-fluorophenyl)carbonylamino]ethyl}-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-7-yl))-2,2,2-trifluoroacetamide
英文别名
N-(6-(3-chloro-(2-thienyl))-5-{2-[(4-fluorophenyl)carbonylamino]ethyl}-4-oxo-(3,4-dihydropyrrolo[3,2-d]pyrimidin-7-yl))-2,2,2-trifluoroacetamide;N-[2-[6-(3-chlorothiophen-2-yl)-4-oxo-7-[(2,2,2-trifluoroacetyl)amino]-3H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-4-fluorobenzamide
N-(6-(3-chloro(2-thienyl))-5-{2-[(4-fluorophenyl)carbonylamino]ethyl}-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-7-yl))-2,2,2-trifluoroacetamide化学式
CAS
846570-74-9
化学式
C21H14ClF4N5O3S
mdl
——
分子量
527.886
InChiKey
IZXLGYGUTCVUAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.65±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    35
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    133
  • 氢给体数:
    3
  • 氢受体数:
    9

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Pyrrolopyrimidine thion derivatives
    摘要:
    一种具有GSK-3抑制功能的化合物。A1和A3是单键,是脂肪烃基;A2和A4是单键,CO,COO,CONR,O,OCO,NR,NRCO,NRCOO等;G1是单键,是脂肪烃,芳香烃,杂环;G2是氢原子,脂肪烃,脂环烃,芳香烃,杂环;A5是单键,NR;R2是H,卤素,脂肪烃,脂环烃,芳香烃,杂环;A6是单键,NR,CO,NRCO,NRCONR,CONR,COO,O等;R3是H,卤素,硝基,饱和脂肪烃,脂环烃,芳香烃,杂环;当A6是CR═CR或C≡C时;R3可以是三甲基硅基,甲酰基,酰基,羧基,烷氧羰基,氨基甲酰,烷基氨基甲酰或氰基;R是H或脂肪烃基。
    公开号:
    US20050153992A1
  • 作为产物:
    描述:
    N-[5-(2-aminoethyl)-6-(3-chloro(2-thienyl))-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-7-yl)]-2,2,2-trifluoroacetamide hydrochloride对氟苯甲酰氯吡啶 作用下, 反应 2.0h, 以78%的产率得到N-(6-(3-chloro(2-thienyl))-5-{2-[(4-fluorophenyl)carbonylamino]ethyl}-4-oxo(3-hydropyrrolo[3,2-d]pyrimidin-7-yl))-2,2,2-trifluoroacetamide
    参考文献:
    名称:
    Pyrrolopyrimidine thion derivatives
    摘要:
    一种具有GSK-3抑制功能的化合物。A1和A3是单键,是脂肪烃基;A2和A4是单键,CO,COO,CONR,O,OCO,NR,NRCO,NRCOO等;G1是单键,是脂肪烃,芳香烃,杂环;G2是氢原子,脂肪烃,脂环烃,芳香烃,杂环;A5是单键,NR;R2是H,卤素,脂肪烃,脂环烃,芳香烃,杂环;A6是单键,NR,CO,NRCO,NRCONR,CONR,COO,O等;R3是H,卤素,硝基,饱和脂肪烃,脂环烃,芳香烃,杂环;当A6是CR═CR或C≡C时;R3可以是三甲基硅基,甲酰基,酰基,羧基,烷氧羰基,氨基甲酰,烷基氨基甲酰或氰基;R是H或脂肪烃基。
    公开号:
    US20050153992A1
点击查看最新优质反应信息

文献信息

  • Pyrrolopyrimidinone derivatives
    申请人:Tsutsumi Takaharu
    公开号:US20060160831A1
    公开(公告)日:2006-07-20
    A compound having GSK-3 inhibitory activity. A 1 and A 3 are a single bond, an aliphatic hydrocarbon group; A 2 and A 4 are a single bond, CO, COO, CONR, O, OCO, NR, NRCO, NRCOO, etc.; G 1 is a single bond, an aliphatic hydrocarbon, aromatic hydrocarbon, heterocyclic; G 2 is H, an aliphatic hydrocarbon, an alicyclic hydrocarbon, an aromatic hydrocarbon, heterocyclic; A 5 is a single bond, NR; R 2 is H, halogen, an aliphatic hydrocarbon, alicyclic hydrocarbon, aromatic hydrocarbon, heterocyclic; A 6 is a single bond, NR, CO, NRCO, NRCONR, CONR, COO, O, etc.; R 3 is H, halogen, nitro, saturated aliphatic hydrocarbon, alicyclic hydrocarbon, aromatic hydrocarbon, heterocyclic; and R 3 may be a trimethylsilyl, formyl, acyl, carboxyl, alkoxylcarbonyl, carbamoyl, alkylcarbamoyl, or cyano group when A 6 is CR═CR or C≡C, wherein R is H or an lower aliphatic hydrocarbon group.
    具有GSK-3抑制活性的化合物。A1和A3是单键,脂肪烃基; A2和A4是单键,CO,COO,CONR,O,OCO,NR,NRCO,NRCOO等; G1是单键,脂肪烃,芳香烃,杂环; G2是H,脂肪烃,脂环烃,芳香烃,杂环; A5是单键,NR; R2是H,卤素,脂肪烃,脂环烃,芳香烃,杂环; A6是单键,NR,CO,NRCO,NRCONR,CONR,COO,O等; R3是H,卤素,硝基,饱和脂肪烃,脂环烃,芳香烃,杂环; 当A6为CR═CR或C≡C时,R3可以是三甲基硅烷基,甲酰基,酰基,羧基,烷氧基羰基,氨基甲酰基,烷基氨甲酰基或氰基。其中R是H或低级脂肪烃基。
  • PYRROLOPYRIMIDINONE DERIVATIVE
    申请人:Teijin Pharma Limited
    公开号:EP1661897A1
    公开(公告)日:2006-05-31
    A compound having GSK-3 inhibitory activity. A1 and A3 are a single bond, an aliphatic hydrocarbon; A2 and A4 are a single bond, CO, COO, etc.; G1 is a single bond, an alicyclic hydrocarbon, aromatic hydrocarbon, etc.; G2 is H, an aliphatic hydrocarbon, an alicyclic hydrocarbon, an aromatic hydrocarbon, etc.; A5 is a single bond, NR; R2 is H, halogen, an aliphatic hydrocarbon, etc.; A6 is a single bond, NR, CO, etc.; R3 is H, halogen, nitro, saturated aliphatic hydrocarbon, etc.; and wherein R is H or an lower aliphatic hydrocarbon group.
    具有 GSK-3 抑制活性的化合物。 A1 和 A3 是单键、脂肪烃;A2 和 A4 是单键、CO、COO 等;G1 是单键、脂环烃、芳香烃等;G2 是 H、脂肪烃、脂环烃、芳香烃等。A5 是单键、NR;R2 是 H、卤素、脂肪烃等;A6 是单键、NR、CO 等;R3 是 H、卤素、硝基、饱和脂肪烃等;其中 R 是 H 或低级脂肪烃基。
  • PYRROLOPYRIMIDINETHIONE DERIVATIVE
    申请人:Teijin Pharma Limited
    公开号:EP1661896A1
    公开(公告)日:2006-05-31
    The present invention relates to a compound having GSK-3 inhibiting function. A1 and A3 are a single bond, an aliphatic hydrocarbon group; A2 and A4 are a single bond, CO, COO, etc.; G1 is a single bond, an alicyclic hydrocarbon, an aromatic hydrocarbon, etc.; G2 is a hydrogen atom, an aliphatic hydrocarbon, an alicyclic hydrocarbon, an aromatic hydrocarbon, etc.; A5 is a single bond, NR; R2 is H, halogen, an aliphatic hydrocarbon, etc.; A6 is a single bond, NR, CO, etc.; R3 is H, halogen, nitro, saturated aliphatic hydrocarbon, etc.; and when R is a hydrogen atom or an aliphatic hydrocarbon group.
    本发明涉及一种具有 GSK-3 抑制功能的化合物。 A1和A3是单键、脂肪烃基;A2和A4是单键、CO、COO等;G1是单键、脂环烃、芳香烃等;G2是氢原子、脂肪烃、脂环烃、芳香烃等。A5 是单键、NR;R2 是 H、卤素、脂肪族烃等;A6 是单键、NR、CO 等;R3 是 H、卤素、硝基、饱和脂肪族烃等;当 R 是氢原子或脂肪族烃基时。
  • US7557113B2
    申请人:——
    公开号:US7557113B2
    公开(公告)日:2009-07-07
  • Pyrrolopyrimidine thion derivatives
    申请人:Tsutsumi Takaharu
    公开号:US20050153992A1
    公开(公告)日:2005-07-14
    A compound having GSK-3 inhibiting function. A 1 and A 3 are a single bond, an aliphatic hydrocarbon group; A 2 and A 4 are a single bond, CO, COO, CONR, O, OCO, NR, NRCO, NRCOO, etc.; G 1 is a single bond, an aliphatic hydrocarbon, aromatic hydrocarbon, heterocyclic; G 2 is a hydrogen atom, an aliphatic hydrocarbon, an alicyclic hydrocarbon, an aromatic hydrocarbon, heterocyclic; A 5 is a single bond, NR; R 2 is H, halogen, an aliphatic hydrocarbon, alicyclic hydrocarbon, aromatic hydrocarbon, heterocyclic; A 6 is a single bond, NR, CO, NRCO, NRCONR, CONR, COO, O, etc.; R 3 is H, halogen, nitro, saturated aliphatic hydrocarbon, alicyclic hydrocarbon, aromatic hydrocarbon, heterocyclic; and when A 6 is CR═CR or C≡C; R 3 may be a trimethylsilyl, formyl, acyl, carboxyl, alkoxylcarbonyl, carbamoyl, alkylcarbamoyl or cyano group; and R is H or an aliphatic hydrocarbon group.
    一种具有GSK-3抑制功能的化合物。A1和A3是单键,是脂肪烃基;A2和A4是单键,CO,COO,CONR,O,OCO,NR,NRCO,NRCOO等;G1是单键,是脂肪烃,芳香烃,杂环;G2是氢原子,脂肪烃,脂环烃,芳香烃,杂环;A5是单键,NR;R2是H,卤素,脂肪烃,脂环烃,芳香烃,杂环;A6是单键,NR,CO,NRCO,NRCONR,CONR,COO,O等;R3是H,卤素,硝基,饱和脂肪烃,脂环烃,芳香烃,杂环;当A6是CR═CR或C≡C时;R3可以是三甲基硅基,甲酰基,酰基,羧基,烷氧羰基,氨基甲酰,烷基氨基甲酰或氰基;R是H或脂肪烃基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐